Granules India Limited and NIPER Join Forces to Establish Dr. Chigurupati Center of Excellence for Sustainable Pharmaceutical Innovation

Hyderabad: Granules India, a prominent vertically integrated pharmaceutical company, has forged a groundbreaking partnership with the prestigious National Institute of Pharmaceutical Education and Research (NIPER) in Mohali, Chandigarh. The collaboration was formalized through the signing of a Memorandum of Understanding (MOU) to create the Dr. Chigurupati Center of Excellence in Innovative and Sustainable Pharmaceutical Development (CCE-ISPD).

This pioneering initiative is set to revolutionize pharmaceutical research and development by placing sustainability and innovation at its core. The center will focus on critical areas, including the exploration of plant-based excipients, advancements in polymer-free pharmaceutical formulations, innovative methods for producing directly compressible crystals, the promotion of solvent-free pharmaceutical processes, and the development of resource-efficient and energy-efficient pharmaceutical products.

The partnership will foster collaborative research initiatives, ensuring a seamless exchange of knowledge between the pharmaceutical industry and academia. Granules India Limited has committed to support the establishment and ongoing operation of the research center, which will feature state-of-the-art laboratories and research facilities within the NIPER campus. This strategic alliance represents a significant step toward emphasizing sustainability within the pharmaceutical sector, promising transformative changes for the industry and society on a global scale.